Cargando…
Nephrotic syndrome associated with metastatic thymoma treated with chemotherapy
RATIONALE: Nephropathy with concurrent invasive thymoma is a type of paraneoplastic syndrome. PATIENT CONCERNS AND DIAGNOSES: We report a 32-year-old female with nephrotic syndrome that was first diagnosed along with invasive thymoma and treated by means of cisplatin-based chemotherapy for the thymo...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5228645/ https://www.ncbi.nlm.nih.gov/pubmed/28072685 http://dx.doi.org/10.1097/MD.0000000000005408 |
_version_ | 1782493979068071936 |
---|---|
author | Yoo, Shin Hye Kim, Hyean-Ji Kim, Jeong-Han Lee, Gyeong-Won Lee, Jeong Hee Kim, Se Hyun Kim, Ji-Won Kim, Jin Won Lee, Jeong-Ok Kim, Yu Jung Lee, Keun-Wook Kim, Jee Hyun Bang, Soo-Mee Lee, Jong Seok |
author_facet | Yoo, Shin Hye Kim, Hyean-Ji Kim, Jeong-Han Lee, Gyeong-Won Lee, Jeong Hee Kim, Se Hyun Kim, Ji-Won Kim, Jin Won Lee, Jeong-Ok Kim, Yu Jung Lee, Keun-Wook Kim, Jee Hyun Bang, Soo-Mee Lee, Jong Seok |
author_sort | Yoo, Shin Hye |
collection | PubMed |
description | RATIONALE: Nephropathy with concurrent invasive thymoma is a type of paraneoplastic syndrome. PATIENT CONCERNS AND DIAGNOSES: We report a 32-year-old female with nephrotic syndrome that was first diagnosed along with invasive thymoma and treated by means of cisplatin-based chemotherapy for the thymoma. The patient initially presented with dyspnea and generalized edema. Chest radiography and computed tomography scans revealed right pleural effusion and a mass in the right middle lung field, which were confirmed by a percutaneous lung biopsy as metastatic invasive thymoma. Severe hypoalbuminemia, heavy proteinuria, hyponatremia, and hypercholesterolemia were features of the nephrotic syndrome. A kidney needle biopsy suggested focal segmental glomerulosclerosis. INTERVENTIONS AND OUTCOMES: All of the symptoms of nephrotic syndrome were resolved simultaneously during the first 2 cycles of chemotherapy. The patient was on regular follow-up with no specific treatment for nephrotic syndrome and underwent successful resection of the left pleura and anterior thymoma. The patient has shown no evidence of recurrence for 2 years. LESSONS: We conclude that chemotherapy for invasive thymoma is an effective treatment for nephrotic syndrome accompanying the thymoma. |
format | Online Article Text |
id | pubmed-5228645 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Wolters Kluwer Health |
record_format | MEDLINE/PubMed |
spelling | pubmed-52286452017-01-25 Nephrotic syndrome associated with metastatic thymoma treated with chemotherapy Yoo, Shin Hye Kim, Hyean-Ji Kim, Jeong-Han Lee, Gyeong-Won Lee, Jeong Hee Kim, Se Hyun Kim, Ji-Won Kim, Jin Won Lee, Jeong-Ok Kim, Yu Jung Lee, Keun-Wook Kim, Jee Hyun Bang, Soo-Mee Lee, Jong Seok Medicine (Baltimore) 5700 RATIONALE: Nephropathy with concurrent invasive thymoma is a type of paraneoplastic syndrome. PATIENT CONCERNS AND DIAGNOSES: We report a 32-year-old female with nephrotic syndrome that was first diagnosed along with invasive thymoma and treated by means of cisplatin-based chemotherapy for the thymoma. The patient initially presented with dyspnea and generalized edema. Chest radiography and computed tomography scans revealed right pleural effusion and a mass in the right middle lung field, which were confirmed by a percutaneous lung biopsy as metastatic invasive thymoma. Severe hypoalbuminemia, heavy proteinuria, hyponatremia, and hypercholesterolemia were features of the nephrotic syndrome. A kidney needle biopsy suggested focal segmental glomerulosclerosis. INTERVENTIONS AND OUTCOMES: All of the symptoms of nephrotic syndrome were resolved simultaneously during the first 2 cycles of chemotherapy. The patient was on regular follow-up with no specific treatment for nephrotic syndrome and underwent successful resection of the left pleura and anterior thymoma. The patient has shown no evidence of recurrence for 2 years. LESSONS: We conclude that chemotherapy for invasive thymoma is an effective treatment for nephrotic syndrome accompanying the thymoma. Wolters Kluwer Health 2017-01-10 /pmc/articles/PMC5228645/ /pubmed/28072685 http://dx.doi.org/10.1097/MD.0000000000005408 Text en Copyright © 2017 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0 |
spellingShingle | 5700 Yoo, Shin Hye Kim, Hyean-Ji Kim, Jeong-Han Lee, Gyeong-Won Lee, Jeong Hee Kim, Se Hyun Kim, Ji-Won Kim, Jin Won Lee, Jeong-Ok Kim, Yu Jung Lee, Keun-Wook Kim, Jee Hyun Bang, Soo-Mee Lee, Jong Seok Nephrotic syndrome associated with metastatic thymoma treated with chemotherapy |
title | Nephrotic syndrome associated with metastatic thymoma treated with chemotherapy |
title_full | Nephrotic syndrome associated with metastatic thymoma treated with chemotherapy |
title_fullStr | Nephrotic syndrome associated with metastatic thymoma treated with chemotherapy |
title_full_unstemmed | Nephrotic syndrome associated with metastatic thymoma treated with chemotherapy |
title_short | Nephrotic syndrome associated with metastatic thymoma treated with chemotherapy |
title_sort | nephrotic syndrome associated with metastatic thymoma treated with chemotherapy |
topic | 5700 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5228645/ https://www.ncbi.nlm.nih.gov/pubmed/28072685 http://dx.doi.org/10.1097/MD.0000000000005408 |
work_keys_str_mv | AT yooshinhye nephroticsyndromeassociatedwithmetastaticthymomatreatedwithchemotherapy AT kimhyeanji nephroticsyndromeassociatedwithmetastaticthymomatreatedwithchemotherapy AT kimjeonghan nephroticsyndromeassociatedwithmetastaticthymomatreatedwithchemotherapy AT leegyeongwon nephroticsyndromeassociatedwithmetastaticthymomatreatedwithchemotherapy AT leejeonghee nephroticsyndromeassociatedwithmetastaticthymomatreatedwithchemotherapy AT kimsehyun nephroticsyndromeassociatedwithmetastaticthymomatreatedwithchemotherapy AT kimjiwon nephroticsyndromeassociatedwithmetastaticthymomatreatedwithchemotherapy AT kimjinwon nephroticsyndromeassociatedwithmetastaticthymomatreatedwithchemotherapy AT leejeongok nephroticsyndromeassociatedwithmetastaticthymomatreatedwithchemotherapy AT kimyujung nephroticsyndromeassociatedwithmetastaticthymomatreatedwithchemotherapy AT leekeunwook nephroticsyndromeassociatedwithmetastaticthymomatreatedwithchemotherapy AT kimjeehyun nephroticsyndromeassociatedwithmetastaticthymomatreatedwithchemotherapy AT bangsoomee nephroticsyndromeassociatedwithmetastaticthymomatreatedwithchemotherapy AT leejongseok nephroticsyndromeassociatedwithmetastaticthymomatreatedwithchemotherapy |